Extended Residual Claims for Maxigienes - 'AERIS ACTIVE' COVID-19 Disinfecting Product in Australia

Updated: Nov 13

  • A World First!

  • Aeris Active granted additional Australian Register of Therapeutic Goods (ARTG) product claims in Australia, further demonstrating technical leadership and product differentiation.

  • ARTG 'on-label' claims now include 'Residual COVID-19 kill for up to seven days' and 'Residual antibacterial for up to 30 days (or 200 touches) against gram-negative E.Coli and gram-positive S.aureus'.

  • Validation studies were conducted at accredited NATA laboratory, Eurofins AMS, that are well known accepted in Australian, Asian and American authorities.



Maxigiene's product development & manufacturing partner Aeris Environmental Ltd is pleased to announce that it has now been granted extended residual protection claims in Australia. These claims are the result of extensive independent scientific testing, validating that Aeris Active provides demonstrated efficacy and proven ability to kill COVID-19 on surfaces, together with an approved residual antibacterial efficacy for up to 30 days (or 200 touches) against the test organisms of gram-negative E.coli and gram-positive S.aureus'.


Aeris Environmental believes it has now established the new 'gold standard' in environmental hygiene, with products that are effective in a single-step application, that have been tested in Option B 'dirty conditions' and meet the hospital grade disinfectant standards.


Importantly, Aeris Active offers validated residual protection on surfaces and is not only effective in killing COVID-19 the fastest (in one minute) but also offers residual protection of the surface, 'actively' killing COVID-19 and offering residual antibacterial protection for up to 30 days (or 200 touches) against gram-negative E.coli and gram positive S.aureus.


Peter Bush, Aeris Environmental CEO:


"I am proud that Aeris is able to offer its proprietary dual-active technology, supported with outstanding 'on-label' claims consistent with an approval set that we are developing internationally. This recognition confirms the 'real world' performance of our products, and I am pleased that this Australian developed, manufactured and patented technology is being recognised globally for its unique position of 'clean-green-protect'.


It is imperative that during this global pandemic products gain the trust of the consumer and deliver on the promise of proven performance."


Charissa Harrison, Maxigiene Australia CEO:


"Maxigiene pride themselves on only bringing the most outstanding products to commercial and industrial businesses. We are committed to offering the best performing range of COVID-19 combatting products to the market and our Australia wide distribution partnership with Aeris Environmental has enabled us to do this. Further testing results like this one and our ability to increase claims on our TGA licence & marketing material ensures we do not make claims about our product performance that cannot be backed up by statistical and scientifically proven data".


"We understand that this pandemic has had such a huge impact on our customers' ability to operate their businesses safely and continually. Our products ability to perform has never been more important" We are proud to represent and have such a great relationship with this leading Global manufacturer."


MAXIGIENE MEDIA RELATIONS

18TH SEPTEMBER 2020

RELATED ARTICLE - ASX RELEASE 28TH AUGUST 2020



20 views

©2020 MAXIGIENE AUSTRALIA PTY LTD | Fawkner Towers Commercial Centre

LEVEL 1 | SUITE 22-23 | 431 ST KILDA ROAD | MELBOURNE | VICTORIA | AUSTRALIA | 3004 

03 9529 2470 charissa@maxigiene.com mobile:  0411 515 515